developing a foxc1-based immunohistochemistry assay for basal-like breast cancer
Published 1 year ago • 119 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
-
53:17
analysis of immune checkpoints in breast and ovarian cancer using multiplex immunohistochemistry
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
3:19
the role of immunohistochemistry in assessing ici efficacy
-
0:15
how a biopsy for cancer diagnosis is done | with help of potato | dr. gaurav gangwani
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
51:49
it is time for time (tumor immune microenvironment) in experimental and diagnostic pathology
-
55:51
her2 testing in breast cancer: improving ihc performance
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
36:33
breast cancer case-based panel discussion | 2022 midwest women's cancer conference
-
1:05:41
role of immunohistochemistry in breast cancer diagnosis
-
5:54
roxane: impact of 21-gene assay on treatment for early breast cancer
-
44:34
utility of trps-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in...
-
14:57
superpathway analyses of luminal and basaloid breast cancers... - christopher benz
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer